Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jun 6:16:65-78.
doi: 10.2147/CEG.S362879. eCollection 2023.

Gastroparesis: Myths, Misconceptions, and Management

Affiliations
Review

Gastroparesis: Myths, Misconceptions, and Management

David J Cangemi et al. Clin Exp Gastroenterol. .

Abstract

Gastroparesis (GP), a historically vexing disorder characterized by symptoms of nausea, vomiting, abdominal pain, early satiety, and/or bloating, in the setting of an objective delay in gastric emptying, is often difficult to treat and carries a tremendous burden on the quality of patients' lives, as well as the healthcare system in general. Though the etiology of GP has been fairly well defined, much work has been done recently to better understand the pathophysiology of GP, as well as to identify novel effective and safe treatment options. As our understanding of GP has evolved, many myths and misconceptions still abound in this rapidly changing field. The goal of this review is to identify myths and misconceptions regarding the etiology, pathophysiology, diagnosis, and treatment of GP, in the context of the latest research findings which have shaped our current understanding of GP. Recognition and dispelling of such myths and misconceptions is critical to moving the field forward and ultimately advancing the clinical management of what will hopefully become a better understood and more manageable disorder in the future.

Keywords: abdominal pain; functional dyspepsia; gastroparesis; nausea; vomiting.

PubMed Disclaimer

Conflict of interest statement

BEL is consultant for Ironwood, Urovant, Salix, Sanofi. The authors report no other conflicts of interest in this work.

Figures

Figure 1
Figure 1
Pathophysiologic mechanisms involved in the generation of gastroparesis symptoms.
Figure 2
Figure 2
Proposed management for the treatment of gastroparesis based on predominant symptom and overall symptom severity.

Similar articles

Cited by

References

    1. Camilleri M, Sanders KM. Gastroparesis. Gastroenterology. 2022;162(1):68–87 e1. doi:10.1053/j.gastro.2021.10.028 - DOI - PMC - PubMed
    1. Camilleri M, Kuo B, Nguyen L, et al. ACG clinical guideline: gastroparesis. Am J Gastroenterol. 2022;117(8):1197–1220. doi:10.14309/ajg.0000000000001874 - DOI - PMC - PubMed
    1. Lacy BE, Crowell MD, Cangemi DJ, et al. Diagnostic evaluation of gastric motor and sensory disorders. Am J Gastroenterol. 2021;116(12):2345–2356. doi:10.14309/ajg.0000000000001562 - DOI - PubMed
    1. Jung HK, Choung RS, Locke GR, et al. The incidence, prevalence and outcomes of patients with gastroparesis in Olmsted County, Minnesota from 1996 to 2006. Gastroenterology. 2009;136:1225–1233. doi:10.1053/j.gastro.2008.12.047 - DOI - PMC - PubMed
    1. Dilmaghani S, Zheng T, Camilleri M. Epidemiology and healthcare utilization in patients with gastroparesis: a systematic review. Clin Gastroenterol Hepatol. 2022. doi:10.1016/j.cgh.2022.07.011 - DOI - PMC - PubMed